CoreTech Limited | Small-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 128.1K
Total Liabilities 655.3K
Shareholders Equity -527.2K

Cash Flow Metrics

Revenue & Profitability Trend

CoreTech Limited Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i15.4K118704.1K
Cost of Goods Sold i73.6K90.0K43.0K112.6K95.6K
Gross Profit i-58.2K-90.0K-43.0K-111.7K-91.5K
Gross Margin % i-379.3%-9,001,000.0%-4,300,500.0%-12,837.4%-2,247.5%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i--32.8K53.1K27.4K
Other Operating Expenses i-3.2K--22.5K-489-946
Total Operating Expenses i-3.2K010.3K52.6K26.5K
Operating Income i-55.0K-98.8K-33.7K-141.7K-121.1K
Operating Margin % i-358.4%-9,878,500.0%-3,368,600.0%-16,289.4%-2,973.7%
Non-Operating Items
Interest Income i90.4K-111
Interest Expense i14.3K9.4K--1.4K
Other Non-Operating Income-----
Pre-tax Income i21.1K-94.7K-56.1K-164.2K-122.5K
Income Tax i-----
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i21.1K-94.7K-56.1K-164.2K-122.5K
Net Margin % i137.3%-9,474,100.0%-5,614,400.0%-18,870.8%-3,007.3%
Key Metrics
EBITDA i35.4K-90.0K-20.5K-111.2K-90.6K
EPS (Basic) i--€0.00€-0.05€-0.04
EPS (Diluted) i--€0.00€-0.05€-0.04
Basic Shares Outstanding i--1340675933258773325877
Diluted Shares Outstanding i--1340675933258773325877

Income Statement Trend

CoreTech Limited Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i12.0K73.3K-2521.1K
Short-term Investments i-85.7K100100100
Accounts Receivable i-----
Inventory i----13.1K
Other Current Assets-----
Total Current Assets i13.0K167.0K13.7K31.9K38.6K
Non-Current Assets
Property, Plant & Equipment i-----
Goodwill i--013.1K43.7K
Intangible Assets i--91.6K13.1K43.7K
Long-term Investments-----
Other Non-Current Assets---22.5K1.4K
Total Non-Current Assets i00035.6K45.0K
Total Assets i13.0K167.0K13.7K67.5K83.6K
Liabilities
Current Liabilities
Accounts Payable i32.8K59.3K72.1K169.0K137.1K
Short-term Debt i-----
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i32.8K59.3K72.1K177.4K140.6K
Non-Current Liabilities
Long-term Debt i728149.4K23.6K814.3K720.1K
Deferred Tax Liabilities i-----
Other Non-Current Liabilities--91.6K-4.0K
Total Non-Current Liabilities i728149.4K23.6K836.7K725.5K
Total Liabilities i33.5K208.7K95.7K1.0M866.1K
Equity
Common Stock i167.8K167.8K1.2M303.8K303.8K
Retained Earnings i-707.4K-728.5K-1.7M-1.7M-1.5M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i-20.6K-41.7K-81.9K-946.7K-782.5K
Key Metrics
Total Debt i728149.4K23.6K814.3K720.1K
Working Capital i-19.9K107.7K-58.3K-145.5K-102.1K

Balance Sheet Composition

CoreTech Limited Cash Flow Statement

No cash flow data available.

CoreTech Limited Key Financial Ratios

Valuation Ratios

Price to Sales 197.86

Profitability Ratios

Profit Margin 137.36%
Operating Margin -405.84%
Return on Equity -102.42%
Return on Assets -43.28%

Financial Health

Current Ratio 0.40
Debt to Equity -0.95
Beta -0.14

Per Share Data

EPS (TTM) €0.00
Book Value per Share €-0.01

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
mlcot3.0M---102.42%137.36%-0.95
Ipsen S.A 9.5B21.492.2610.89%11.91%22.74
Vetoquinol S.A 887.3M15.101.5410.64%10.88%3.67
AB Science S.A 83.1M-8.60-32.97%116.42%-0.78
Boiron S.A 392.4M34.771.042.95%2.33%3.96
Euroapi S.A.S.U 301.9M8.840.40-13.49%-14.08%7.17

Financial data is updated regularly. All figures are in the company's reporting currency.